2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | PHARMACOLOGY & THERAPEUTICS PHARMACOL THERAPEUT （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.0
53人评分
我要评分
声誉 10.0 影响力 8.5 速度 7.0 | |||||||||||||||||||||
| 期刊ISSN | 0163-7258 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1879-016X | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：13.5 | |||||||||||||||||||||
| 2025-2026自引率 | 0.7%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 16.197数据由网友[star6830]收集提供 | |||||||||||||||||||||
| h-index | 180 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.journals.elsevier.com/pharmacology-and-therapeutics/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/PANDT | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential Author: Nisar, Ayesha; Khan, Sawar; Li, Wen; Zhang, Xuan; He, Yonghan Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109055 Disarming the Neural Hijack: Repurposing neuroactive drugs for cancer therapy Author: Jin, Ming-Zhu; Dang, Hao-Ran; Jin, Wei-Lin Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109051 Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics Author: Ding, Huanyu; Cheng, Chak Kwong; Jiang, Minchun; Cheng, Xiang; Huang, Yu Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109053 Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers Author: Zou, Qinhong; Yang, Xiaoyan Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109054 | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足PHARMACOLOGY & THERAPEUTICS的语言要求，还能让PHARMACOLOGY & THERAPEUTICS编辑和审稿人得到更好的审稿体验，让稿件最大限度地被PHARMACOLOGY & THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB | |||||||||||||||||||||
| 出版商 | Elsevier Inc. | |||||||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1979 | |||||||||||||||||||||
| 年文章数 | 90点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 30.64% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 0.00% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0163-7258%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 偏慢,4-8周 来源Elsevier官网： 平均15.8周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较难 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在PHARMACOLOGY & THERAPEUTICS顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均11.8周 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential Author: Nisar, Ayesha; Khan, Sawar; Li, Wen; Zhang, Xuan; He, Yonghan Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109055 PubMed DOI |
| 2. | Disarming the Neural Hijack: Repurposing neuroactive drugs for cancer therapy Author: Jin, Ming-Zhu; Dang, Hao-Ran; Jin, Wei-Lin Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109051 PubMed DOI |
| 3. | Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics Author: Ding, Huanyu; Cheng, Chak Kwong; Jiang, Minchun; Cheng, Xiang; Huang, Yu Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109053 PubMed DOI |
| 4. | Circular RNA serves as an upstream regulator of the miRNA//ABCC1 axis in human cancers Author: Zou, Qinhong; Yang, Xiaoyan Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109054 PubMed DOI |
| 5. | A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles Author: Zhang, Jiali; Wang, Xiangyu; Liu, Xingang; Zhao, Jingjing; Feng, Haoyu; Zhang, Fan; Wang, Yunsheng; Zhang, Yang; Xu, Yanfang; Jia, Qingzhong Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109052 PubMed DOI |
| 6. | The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation Author: Li, Huiyu; Lei, Xiaoyong; Yang, Xiaoyan Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 285, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109069 PubMed DOI |
| 7. | Current drug treatment methods and potential significance of glucocorticoid for inoperable advanced thymoma Author: Yu, Xin-tao; Cui, Jian; Gao, Xiang; Yang, Xing-guo; Wang, Sheng-dian; Yu, Lei Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 284, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109039 PubMed DOI |
| 8. | Advances in iron-based chemodynamic anti-cancer therapy Author: Dai, Yuying; An, Lu Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 283, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109028 PubMed DOI |
| 9. | P2Y14 receptor in the nervous system: Pharmacology, mechanisms, and therapeutic potential Author: Lin, Jiu; Su, Xin; Feng, Xiaoxia; Mao, Yingjie; Zhang, Xia; Gan, Feihong; Chen, Qianming; Ciruela, Francisco; Wang, Zhiyong; Fang, Xinyi Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 282, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109001 PubMed DOI |
| 10. | Innate immune responses following myocardial ischemia and reperfusion: Evidence, mechanisms, and translational challenges Author: Zhang, Shuya; Du, Pengju; Zhang, Cheng; Jie, Wei; Shi, Guo-Ping; Guo, Junli Journal: PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 282, Issue , pp. -. DOI: 10.1016/j.pharmthera.2026.109026 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共1条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
